Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Takeda Pharmaceutical Company Limited
FDA Inspection
•Takeda Pharmaceutical Company Limited•August 9, 2019

Takeda Pharmaceutical Company Limited – FDA Inspection, Aug 9, 2019

Record Details

This FDA Inspection record concerns Takeda Pharmaceutical Company Limited, with an inspection on August 9, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Takeda Pharmaceutical Company Limited
Inspection Date
August 9, 2019
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Gam S. Zamil (Company Rep)
  • Patric C. Klotzbuecher (Issuing Officer)
View Company Profile

ID · 6b7bfbeb-8fc3-4f6b-bd3d-15134d511a79

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1100693
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

FDA Citations

4
  1. 21 CFR 211.100(b)Procedure Deviations Recorded and Justified
  2. 21 CFR 211.160(b)Scientifically sound laboratory controls
  3. 21 CFR 211.194(a)Complete test data included in records
  4. 21 CFR 211.113(b)Validation lacking for sterile drug products

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Takeda Pharmaceutical Company Limited

6
DateClassificationOfficeProject area
April 12, 2024NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
August 29, 2017NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
September 18, 2015VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
September 6, 2013VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
August 2, 2012VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 6 other inspections on the company page
Other documents for Takeda Pharmaceutical Company Limited
  • FDA Inspection 1238763 - 2024-04-12
  • FDA Inspection 1028828 - 2017-08-29
  • FDA Inspection 943082 - 2015-09-18
  • FDA Inspection 853928 - 2013-09-06
  • FDA Inspection 793427 - 2012-08-02

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Takeda Pharmaceutical Company Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.